Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Revolution Medicines Inc 700 Saginaw Drive Redwood City CA 94063 USA

www.revmed.com P: 650-481-6801

Description:

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 6,502,098
Enterprise Value, $K 5,805,948
Shares Outstanding, K 164,986
Annual Sales, $ 11,580 K
Annual Net Income, $ -436,370 K
Last Quarter Sales, $ 740 K
Last Quarter Net Income, $ -161,540 K
EBIT, $ -487,190 K
EBITDA, $ -500,090 K
60-Month Beta 1.46
% of Insider Shareholders 8.50%
% of Institutional Shareholders 94.34%
Float, K 150,962
% Float 91.50%
Short Volume Ratio 0.59

Growth:

1-Year Return 52.11%
3-Year Return 25.55%
5-Year Return 0.00%
5-Year Revenue Growth -42.59%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.70 on 05/08/24
Latest Earnings Date N/A
Earnings Per Share ttm -3.77
EPS Growth vs. Prev Qtr 38.60%
EPS Growth vs. Prev Year 2.78%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RVMD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.41%
Return-on-Assets % -32.13%
Profit Margin % -3,768.31%
Debt/Equity 0.00
Price/Sales 555.51
Price/Cash Flow N/A
Price/Book 3.85
Book Value/Share 11.09
Interest Coverage -1,465.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar